Cytokine PharmaSciences News
Please see below for a list of recent and historic press releases.- November 30, 2009
Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 - July 20, 2009
Cytokine PharmaSciences Initiates Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 - February 25, 2008
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment - October 29, 2007
Cytokine Announces Oral Efficacy of Anti-Cytokine Semapimod - August 2, 2007
Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors - May 3, 2007
Cytokine PharmaSciences, Inc. Issued Patent for MIF Gene Polymorphism Diagnostics - November 29, 2006
Beijing Med-Pharm Corporation and Cytokine PharmaSciences, Inc. Research Agreement on Development and Commercialization of Second-Generation Obstetrics Product in China - March 13, 2003
Cytokine PharmaSciences Licenses Anti-MIF Technology to Baxter Healthcare Corporation